主任医师，副教授，硕士生导师，医学博士

美国纽约斯隆凯特琳癌症中心（MSKCC）访问学者 

专业特长：

1. 结直肠癌外科治疗

2. 结直肠癌个体化新辅助治疗，直肠癌器官保留和等待观察疗法

3. 结直肠癌超加速康复外科（Hyper-ERAS）

4. 恶性肠梗阻和腹盆腔转移癌的外科治疗 

学术成就：

美国结直肠外科医师年会（ASCRS），受邀大会发言最多的中国医生（2009/2014/2020）；

完成省部级基金4项； 

代表性著作：

1. Wang, L., Zhang, X.Y.,et al., Intentional Watch and Wait or Organ Preservation Surgery FollowingNeoadjuvant Chemoradiotherapy Plus Consolidation CAPEOX for MRI-defined Low-riskRectal Cancer: Findings From a Prospective Phase 2 Trial (PKUCH-R01 Trial, NCT02860234).Ann Surg, 2023. 277(4): p. 647-654.

2. Zhang, X.Y., Wang, L et al., Predicting Rectal Cancer Response to Neoadjuvant Chemoradiotherapy Using Deep Learning of Diffusion Kurtosis MRI. Radiology, 2020. 296(1): p. 56-64.

3. Chinese W, Wait Database Research Cooperation G, Chinese Society of Colorectal S, Chinese Medical A, Colorectal Cancer Physician Specialty C, Colorectal Cancer C. [Chinese expert consensus on the watch and wait strategy in rectal cancer patients after neoadjuvant treatment (2024 version)]. Zhonghua wei chang wai ke za zhi = Chinese journal of gastrointestinal surgery. 2024;27(4):301-15. 10.3760/cma.j.cn441530-20240227-00075.

4. Li, C., et al., Predictors of pathologic complete response in patients with residual flat mucosal lesions after neoadjuvant chemoradiotherapy for locally advanced rectal cancer. Chin J Cancer Res, 2022. 34(4): p. 383-394.

5. Chen, P.J., et al., Total neoadjuvant treatment for MRI-stratified high-risk rectal cancer: asingle-center, single-arm, prospective Phase II trial (PKUCH-R02). Gastroenterol Rep (Oxf),2023. 11: p. goad017.